Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Mayes

Showing results (181-190 of 382) with videos related to

Pageof 39
Sort By:
Arthritis and Rheumatism|July 20, 2011
A one-year, phase I/IIa, open-label pilot trial of imatinib mesylate in the treatment of systemic sclerosis-associated active interstitial lung diseaseDinesh Khanna, Rajeev Saggar, Maureen D Mayes, et al.
The Journal of Rheumatology|February 3, 2019
Predictors of Hand Contracture in Early Systemic Sclerosis and the Effect on Function: A Prospective Study of the GENISOS CohortMaryam Buni, Joyce Joseph, Claudia Pedroza, et al.
Plos One|November 9, 2013
Right bundle branch block: a predictor of mortality in early systemic sclerosisHilda T Draeger, Shervin Assassi, Roozbeh Sharif, et al.
Clinical and Experimental Rheumatology|August 29, 2015
Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survivalMichael Wodkowski, Marie Hudson, Susanna Proudman, et al.
Arthritis and Rheumatism|October 12, 2012
Correlation of interferon-inducible chemokine plasma levels with disease severity in systemic sclerosisXiaochun Liu, Maureen D Mayes, Filemon K Tan, et al.
Journal of Autoimmunity|March 13, 2010
Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosisRajpreet K Arora-Singh, Shervin Assassi, Deborah J del Junco, et al.
The Journal of Rheumatology|November 18, 2009
Association of interleukin 23 receptor polymorphisms with anti-topoisomerase-I positivity and pulmonary hypertension in systemic sclerosisSandeep K Agarwal, Pravitt Gourh, Sanjay Shete, et al.
Annals of the Rheumatic Diseases|August 16, 2022
Continued treatment with nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from SENSCIS-ONYannick Allanore, Madelon C Vonk, Oliver Distler, et al.
Arthritis and Rheumatism|June 8, 2011
Cigarette smoking is not a risk factor for systemic sclerosisPrateek Chaudhary, Xing Chen, Shervin Assassi, et al.
Arthritis and Rheumatism|October 2, 2007
Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrumentDinesh Khanna, Ron D Hays, Grace S Park, et al.
Pageof 39

Showing results (181-190 of 382) with videos related to

Sort By:
Pageof 39
Arthritis and Rheumatism|July 20, 2011
A one-year, phase I/IIa, open-label pilot trial of imatinib mesylate in the treatment of systemic sclerosis-associated active interstitial lung diseaseDinesh Khanna, Rajeev Saggar, Maureen D Mayes, et al.
The Journal of Rheumatology|February 3, 2019
Predictors of Hand Contracture in Early Systemic Sclerosis and the Effect on Function: A Prospective Study of the GENISOS CohortMaryam Buni, Joyce Joseph, Claudia Pedroza, et al.
Plos One|November 9, 2013
Right bundle branch block: a predictor of mortality in early systemic sclerosisHilda T Draeger, Shervin Assassi, Roozbeh Sharif, et al.
Clinical and Experimental Rheumatology|August 29, 2015
Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survivalMichael Wodkowski, Marie Hudson, Susanna Proudman, et al.
Arthritis and Rheumatism|October 12, 2012
Correlation of interferon-inducible chemokine plasma levels with disease severity in systemic sclerosisXiaochun Liu, Maureen D Mayes, Filemon K Tan, et al.
Journal of Autoimmunity|March 13, 2010
Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosisRajpreet K Arora-Singh, Shervin Assassi, Deborah J del Junco, et al.
The Journal of Rheumatology|November 18, 2009
Association of interleukin 23 receptor polymorphisms with anti-topoisomerase-I positivity and pulmonary hypertension in systemic sclerosisSandeep K Agarwal, Pravitt Gourh, Sanjay Shete, et al.
Annals of the Rheumatic Diseases|August 16, 2022
Continued treatment with nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from SENSCIS-ONYannick Allanore, Madelon C Vonk, Oliver Distler, et al.
Arthritis and Rheumatism|June 8, 2011
Cigarette smoking is not a risk factor for systemic sclerosisPrateek Chaudhary, Xing Chen, Shervin Assassi, et al.
Arthritis and Rheumatism|October 2, 2007
Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrumentDinesh Khanna, Ron D Hays, Grace S Park, et al.
Pageof 39